Magnetic N-succinyl chitosan/alginate beads for carbamazepine delivery

References

• Chang BS, Lowenstein DH. (2003). Epilepsy. N Engl J Med, 349:1257–66.
   PubMed Web of Science ®Google Scholar
• Kwan P, Brodie MJ. (2000). Early identification of refractory epilepsy. N Engl J Med, 342:314–9.
   PubMed Web of Science ®Google Scholar
• Ramon C, Holmes MD, Haueisen J, Schimpf PH, Freeman WJ. (2007). Scalp potentials and magnetic fields of a fully and partially activated central sulcus. Int Congr Ser, 1300:157–60.
   Google Scholar
• Jung H, Milán RC, Girard ME, León F, Montoya MA. (1997). Bioequivalence study of carbamazepine tablets: In vitro/in vivo correlation. Int J Pharm, 152:37–44.
   Web of Science ®Google Scholar
• El-Massik MA, Abdallah OY, Galal S, Daabis NA. (2006). Towards a universal dissolution medium for carbamazepine. Drug Dev Ind Pharm, 32:893–905.
   PubMed Web of Science ®Google Scholar
• Sethia S, Squillante E. (2002). Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. J Pharm Sci, 91:1948–57.
   PubMed Web of Science ®Google Scholar
• Sethia S, Squillante E. (2004). Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm, 272:1–10.
   PubMed Web of Science ®Google Scholar
• Rustichelli C, Gamberini G, Ferioli V, Gamberini MC, Ficarra R, Tommasini S. (2000). Solid-state study of polymorphic drugs: Carbamazepine. J Pharm Biomed Anal, 23:41–54.
   PubMed Web of Science ®Google Scholar
• Dong WY, Maincent P, Bodmeier R. (2007). In vitro and in vivo evaluation of carbamazepine-loaded enteric microparticles. Int J Pharm, 331:84–92.
   PubMed Web of Science ®Google Scholar
• Boison D. (2009). Engineered adenosine-releasing cells for epilepsy therapy: Human mesenchymal stem cells and human embryonic stem cells. Neurotherapeutics, 6:278–83.
   PubMed Web of Science ®Google Scholar
• Vajda FJE. (2007). Pharmacotherapy of epilepsy: New armamentarium, new issues. J Clin Neurosci, 14:813–23.
   PubMed Web of Science ®Google Scholar
• Nilsen KE, Cock HR. (2004). Focal treatment for refractory epilepsy: Hope for the future? Brain Res Brain Res Rev, 44:141–53.
   PubMed Web of Science ®Google Scholar
• Kato Y, Onishi H, Machida Y. (2004). N-succinyl-chitosan as a drug carrier: Water-insoluble and water-soluble conjugates. Biomaterials, 25:907–15.
   PubMed Web of Science ®Google Scholar
• Yan CY, Chen DW, Gu JW, Hu HY, Zhao XL, Qiao MX. (2006). Preparation of N-succinyl-chitosan and their physical–chemical properties as a novel excipient. Pharm Soc Japan, 126:789–93.
   Web of Science ®Google Scholar
• Chen LY, Tian ZG, Du YM. (2004). Synthesis and pH sensitivity of carboxymethyl chitosan-based polyampholyte hydrogels for protein carrier matrices. Biomaterials, 25:3725–32.
   PubMed Web of Science ®Google Scholar
• Liu ZH, Jiao YP, Zhang ZY. (2007). Calcium–carboxymethyl chitosan hydrogel beads for protein drug delivery system. J Appl Polym Sci, 103:3164–8.
   Web of Science ®Google Scholar
• Yan LF, Qian F, Zhu QS. (2001). Interpolymer complex polyampholytic hydrogel of chitosan and carboxymethyl cellulose (CMC): Synthesis and ion effect. Polym Int, 50:1370–4.
   Web of Science ®Google Scholar
• Yang WC, Xie R, Pang XQ, Ju XJ, Chu LY. (2008). Preparation and characterization of dual stimuli-responsive microcapsules with a superparamagnetic porous membrane and thermo-responsive gates. J Memb Sci, 321:324–30.
   Web of Science ®Google Scholar
• Liu XQ, Kaminski MD, Chen HT, Torno M, Taylor LT, Rosengart AJ. (2007). Synthesis and characterization of highly-magnetic biodegradable poly (D,L-lactide-co-glycolide) nanospheres. J Control Release, 119:52–8.
   PubMed Web of Science ®Google Scholar
• Dai YN, Li P, Zhang JP, Wang AQ, Wei Q. (2008). A novel pH sensitive N-succinyl chitosan/alginate hydrogel bead for nifedipine delivery. Biopharm Drug Dispos, 29:173–84.
   PubMed Web of Science ®Google Scholar
• Dai YN, Li P, Zhang JP, Wang AQ, Wei Q. (2008). Swelling characteristics and drug delivery properties of nifedipine-loaded pH sensitive alginate–chitosan hydrogel beads. J Biomed Mater Res, 86B:493–500.
   Web of Science ®Google Scholar
• Elizabeth J, Donner O. (2006). Carter Snead III. New generation anticonvulsants for the treatment of epilepsy in children. NeuroRX, 3:170–80.
   PubMedGoogle Scholar
• Mladenovska K, Cruaud O, Richommed P, Belamie E, Raicki RS, Venier-Julienne MC, . (2007). 5-ASA loaded chitosan–Ca–alginate microparticles: Preparation and physicochemical characterization. Int J Pharm, 345:59–69.
   PubMed Web of Science ®Google Scholar
• Shu XZ, Zhu KJ. (2002). The release behavior of brilliant blue from calcium–alginate gel beads coated by chitosan: The preparation method effect. Eur J Pharm Biopharm, 53:193–201.
   PubMed Web of Science ®Google Scholar
• Sankalia MG, Mashru RC, Mashru JM, Sutariya VB. (2007). Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physicochemical characterization. Eur J Pharm Biopharm, 65:215–32.
   PubMed Web of Science ®Google Scholar
• Chen SC, Wu YC, Mi FL, Lin YH, Yu LC, Sung HW. (2004). A novel pH-sensitive hydrogel composed of N, O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J Control Release, 96:285–300.
   PubMed Web of Science ®Google Scholar
• Hoffman AS. (2002). Hydrogels for biomedical applications. Adv Drug Deliv, 43:3–12.
   Web of Science ®Google Scholar
• Xu YM, Zhan CY, Fan LH, Wang L, Zheng H. (2007). Preparation of dual crosslinked alginate–chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system. Int J Pharm, 336:329–37.
   PubMed Web of Science ®Google Scholar
• Xi FN, Wu JM, Jia ZS, Lin XF. (2005). Preparation and characterization of trypsin immobilization on silica gel supported macroporous chitosan bead. Process Biochem, 40:2833–40.
   Web of Science ®Google Scholar